Onconetix, Inc. (ONCO) Dividend History

Onconetix, Inc. (ONCO) is a biotechnology company focused on the development of diagnostic and therapeutic solutions for cancer detection and treatment. The company specializes in leveraging advanced molecular and genomic technologies to improve the accuracy and effectiveness of cancer diagnostics, aiming to enhance personalized medicine and patient outcomes.

201 E. Fifth Street, Cincinnati, OH, 45202
Phone: 513-620-4101
Website: https://www.onconetix.com

Dividend History

Onconetix, Inc. currently does not pay dividends

Company News

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix and Ocuvex Therapeutics have signed a definitive merger agreement where Onconetix will acquire Ocuvex, with Ocuvex shareholders receiving 90% of the combined company's equity. The transaction is expected to close in Q4 and aims to bring ophthalmic therapeutic assets to the public markets.

Benzinga
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewswire

Onconetix, Inc. announced the closing of the exercise of existing warrants and the issuance of new warrants in a private placement, raising approximately $1.11 million. The company plans to use the proceeds for working capital and general corporate purposes.

GlobeNewswire Inc.

Page data last updated 07/23/2025 06:21:57 UTC